*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Susceptibility of ABO system for infection of COVID-19

Author: IHSAN ALI ALZAMILY, AYAD KADHIM FADHIL
Abstract: COVID 19 is a contagious viral disease caused via SARS CoV 2 appeared at Wuhan ,the chinese city, which has spread worldwide. SARSCoV-2 has been shown to be relatively associated with bat {SARS-like} viruses, and therefore bats may be a potential reservoir of infection. origin and transmission for humans is unknown, but rapid transmission from humans to humans has been confirmed widely. O glycosylation plays a major role in causing coronavirus infection, which creates an antigenic structure,virus can not survive outside its host and by default uses cells of the host. Host cell adhesion to the virus occurs mainly independently of blood type ABO via a genetically unspecified evolutionary structure , and appears to act as a pathogen host pathway functional for many contagious diseases. however, while susceptibility and severity depend on several factors such as individuals of A blood type who unable to respond to acquired or inherent antibodies for synthesize hybrid ((A-like)) formations due to the selection of clonal and plasma protein adaptation Thus individuals with a blood group A will be a preferred target of the virus that uses glycotransferase to phenotype, and leads to more hybrid correlation of the blood type A-allelic type of hybrid while associated O individuals with the lowest risk to be infected.
Keyword: ABO system, SARS CoV 2, A antigen, ACE2 , blood group O
DOI: https://doi.org/10.31838/ijpr/2020.12.02.353
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free